P2-13 preliminary RCT analysis of minimally invasive surgery VS. medication in the initial treatment of BPH-associated luts
Abstract
You have accessJournal of UrologyParadigm-shifting, Practice-changing Clinical Trials in Urology (P2)1 May 2024P2-13 PRELIMINARY RCT ANALYSIS OF MINIMALLY INVASIVE SURGERY VS. MEDICATION IN THE INITIAL TREATMENT OF BPH-ASSOCIATED LUTS Philip Brodak, Shadi Tarazi, Prithipal Sethi, Michael Trotter, Dean Elterman, Sheldon Freedman, Sean Heron, Nilay Gandhi, Todd Bertoch, Gregg Eure, Wiliam Brad Roth, Thomas Mueller, Brian Mazzarella, and Claus Roehrborn Philip BrodakPhilip Brodak , Shadi TaraziShadi Tarazi , Prithipal SethiPrithipal Sethi , Michael TrotterMichael Trotter , Dean EltermanDean Elterman , Sheldon FreedmanSheldon Freedman , Sean HeronSean Heron , Nilay GandhiNilay Gandhi , Todd BertochTodd Bertoch , Gregg EureGregg Eure , Wiliam Brad RothWiliam Brad Roth , Thomas MuellerThomas Mueller , Brian MazzarellaBrian Mazzarella , and Claus RoehrbornClaus Roehrborn View All Author Informationhttps://doi.org/10.1097/01.JU.0001015816.87470.c9.13AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are initially treated with medical therapy or watchful waiting; medical therapy non-adherence is high due to low efficacy, sexual dysfunction, and undesirable adverse events. The Prostatic Urethral Lift (PUL) and other minimal invasive surgical therapies (MISTs) offer durable relief from symptoms,…
Read the paper
Related studies
- Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling
- Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
- Luteolin Inhibits Dexamethasone‐Induced Osteoporosis by Autophagy Activation Through miR‐125b‐5p/SIRT3/AMPK/mTOR Axis, an In Vitro and In Vivo Study
- Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
- Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI‐RS 2023
- Chylomicron-mimicking supramolecular nano emulsion for oral luteolin delivery against hyperuricemia
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.